INT193486

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.34
First Reported 2006
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 2.21
Pain Relevance 0.68

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (Nos3) aging (Nos3) Golgi apparatus (Nos3)
cytoplasm (Nos3) signal transduction (Nos3) oxidoreductase activity (Nos3)
Anatomy Link Frequency
retinas 2
leukocyte 2
Nos3 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
ischemia 86 99.62 Very High Very High Very High
Inflammation 54 98.04 Very High Very High Very High
Bioavailability 1 87.16 High High
cva 8 59.68 Quite High
Inflammatory response 10 50.00 Quite Low
Inflammatory stimuli 3 14.56 Low Low
medulla 1 7.44 Low Low
cytokine 9 5.00 Very Low Very Low Very Low
Inflammatory mediators 6 5.00 Very Low Very Low Very Low
chemokine 5 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cv Unclassified Under Development 85 99.62 Very High Very High Very High
Diabetes Mellitus 17 99.48 Very High Very High Very High
INFLAMMATION 73 98.04 Very High Very High Very High
Adhesions 25 89.64 High High
Diabetic Macular Edema 26 72.92 Quite High
Disease 4 67.64 Quite High
Targeted Disruption 2 62.80 Quite High
Pressure Volume 2 Under Development 1 60.36 Quite High
Cv General 3 Under Development 3 59.68 Quite High
Injury 10 58.00 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Induction of short time (60 min) Isc, in control rats, produced a loss in the glomerular eNOS and an increase of its interstitial expression (c).
Negative_regulation (produced) of Negative_regulation (loss) of eNOS associated with ischemia
1) Confidence 0.34 Published 2006 Journal BMC Nephrol Section Body Doc Link PMC1501003 Disease Relevance 0.71 Pain Relevance 0.37
Animals treated with selective iNOS inhibitors (aminoguanidine, 1400W, L-NIL and AE-ITU) or a selective eNOS inhibitor (L-NIO) present enhanced leukocyte migration to inflammatory sites [25, 27, 40, 41].
Negative_regulation (inhibitors) of Negative_regulation (inhibitor) of eNOS in leukocyte associated with inflammation
2) Confidence 0.31 Published 2010 Journal Mediators of Inflammation Section Body Doc Link PMC2879545 Disease Relevance 0.76 Pain Relevance 0.28
Fasudil treatment almost completely reversed the decreased eNOS activity in diabetic rat retinas.
Negative_regulation (reversed) of Negative_regulation (decreased) of eNOS in retinas associated with diabetes mellitus
3) Confidence 0.18 Published 2010 Journal Journal of Ophthalmology Section Body Doc Link PMC2905943 Disease Relevance 0.74 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox